Cai Lay Vet Pharma establishes new subsidiary with VND50bn charter capital
Cai Lay Veterinary Pharmaceutical JSC's shareholders, representing 89.05% of voting shares, have approved the establishment of a one-member limited liability company, Cai Lay Veterinary Pharmaceutical Company Limited. The decision was reached through a written consultation, with 88.94% voting in favor.
The new subsidiary will have a charter capital of VND50,000,000,000, with contributions including assets valued at VND43,989,501,553 and a cash contribution of VND6,021,498,447. The board of directors is tasked with overseeing the registration and capital contribution process.
The new company's business activities will mirror those of the parent company, focusing on veterinary medicine production, animal feed, poultry, and aquaculture, along with other related business lines. The chairman of the parent company's board of directors will serve as the legal representative for the new subsidiary.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Cai Lay Veterinary Pharmaceutical JSC publishes news
Free account required • Unsubscribe anytime